ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,307.01
      -0.27%
      US Tech 100
      18,426.40
      1.09%
      Dow Jones
      39,671.04
      0.00%
      Brent Oil
      82.275
      0.91%
      Bitcoin
      69,956.77
      1.24%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. TCR2 Therapeutics Inc (TCRR)

      7. TCR2 Therapeutics Inc (TCRR) News

      TCRR

      TCR2 Therapeutics (TCRR)

      TCR2 Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TCRR
      DateTimeSourceHeadlineSymbolCompany
      06/12/20237:01AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/06/20236:03AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/06/20236:03AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/06/20236:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/05/20234:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/05/20234:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/05/20234:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/05/20234:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20234:46PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20234:44PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20234:42PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20234:41PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20234:40PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20234:39PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20234:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20234:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20234:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20234:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20234:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20234:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20234:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20239:35AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/30/20234:22PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/30/20234:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/24/20234:57PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/24/20234:53PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/24/20234:53PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/24/20234:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/24/20234:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/22/20237:34AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TCRRTCR2 Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:TCRR